To identify whether serum OPG and TRAIL levels were regulated in the participants with diabetes, serum OPG and TRAIL levels were compared between 35 patients with diabetes (the “DM” group) and 36 participants without diabetes (the “non-DM” group). The gene discussed is TNFRSF11B; the disease is diabetes mellitus.